Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04891211
Other study ID # EA180919
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 12, 2021
Est. completion date March 10, 2021

Study information

Verified date May 2021
Source Adiyaman University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Retinal tissue parameters of pediatric patients with vitamin D deficiency will be evaluated in this prospective case-control study. The patients will be divided into 2 groups according to the vitamin D level. Retinal vessel diameters, retinal nerve fiber evaluation, choroidal thickness will be evaluated. Choroidal thinning decrease in retinal artery diameter and increase in retinal vein diameter will be detected in the vitamin D deficiency group.


Description:

The study of the relationship between vitamin D status and retinal diseases is a new concept, and there is a large gap in research focusing on the pediatric population in the literature. The importance of vitamin D in retinal maturation and its role in the development of retinal diseases at a young age is being investigated. In this sense, as far as known, it is the first study investigating retinal structure parameters in pediatric patients with vitamin D deficiency.


Recruitment information / eligibility

Status Completed
Enrollment 150
Est. completion date March 10, 2021
Est. primary completion date March 1, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 8 Years to 17 Years
Eligibility Inclusion Criteria:(Group 1): 1. age <18 years old 2. serum vitamin D [(25(OH) D), calcitriol] level <20 ngr/mL in previous two weeks 3. visual acuity >20/20 4. manifest refraction spherical equivalent <3D 5. normal biomicroscopic and fundus examination. Exclusion Criteria: 1. history of any chronic ocular diseases, except for refractive error (e.g., uveitis, glaucoma, retinopathy of prematurity) 2. history of ocular surgery (e.g., cataract, strabismus, open globe injury, laser photocoagulation) 3. having an ocular abnormality (e.g., persistent fetal vasculature, optic disc hypoplasia, fovea plana) 4. history of systemic diseases that have the potential to affect ocular tissues (e.g., diabetes mellitus, Graves' disease, albinism, Down syndrome, Fabry diseases, Wilson syndrome) 5. history of any systemic diseases that can affect the serum vitamin D level (e.g., parathormone or calcium metabolism disorders) 6. already receiving vitamin D treatment.

Study Design


Intervention

Dietary Supplement:
Vitamin D deficiency
Ocular significance of vitamin D deficiency in pediatric cases

Locations

Country Name City State
Turkey Adiyaman U Adiyaman None Selected

Sponsors (1)

Lead Sponsor Collaborator
Adiyaman University

Country where clinical trial is conducted

Turkey, 

References & Publications (1)

Poon M, Craig ME, Kaur H, Cusumano J, Sasongko MB, Wong TY, Donaghue KC. Vitamin D deficiency is not associated with changes in retinal geometric parameters in young people with type 1 diabetes. J Diabetes Res. 2013;2013:280691. doi: 10.1155/2013/280691. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary choroidal thickness subfoveal, and subfoveal 1500-µm- and 3000-µm-diameter distance nasal and temporal areas up to 3 months
Primary retinal nerve fiber layer Retinal nerve fiber layer will be detected by optical coherence tomography up to 3 months
Primary The central retinal artery and vein calibers The central retinal artery and vein calibers will be analyzed with the Interactive Vessel Analyzer up to 3 months
Secondary blood vitamin D levels vitamin D deficiency or normal effects of vitamin D deficiency up to 3 months
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04244474 - Effect of Vitamin D Supplementation on Improvement of Pneumonic Children Phase 1/Phase 2
Recruiting NCT05459298 - ViDES Trial (Vitamin D Extra Supplementation) N/A
Completed NCT04476511 - The Efficacy and the Safety of Vitamin D3 30,000 IU for Loading Dose Schedules Phase 3
Suspended NCT03652987 - Endocrine and Menstrual Disturbances in Women With Polycystic Ovary Syndrome (PCOS)
Completed NCT03920150 - Vitamin D 24'000 IU for Oral Intermittent Supplementation Phase 3
Completed NCT03264625 - The Effects of Oral Vitamin D Supplementation on the Prevention of Peritoneal Dialysis-related Peritonitis Phase 2
Completed NCT04183257 - Effect of Escalating Oral Vitamin D Replacement on HOMA-IR in Vitamin D Deficient Type 2 Diabetics Phase 4
Recruiting NCT05084248 - Vitamin D Deficiency in Adults Following a Major Burn Injury Phase 4
Completed NCT05506696 - Vitamin D Supplementation Study N/A
Completed NCT00092066 - A Study to Evaluate the Safety, Tolerability, and Efficacy of an Investigational Drug and Dietary Supplement in Men and Postmenopausal Women With Osteoporosis (0217A-227) Phase 3
Completed NCT03234218 - Vitamin D Levels in Liver Transplantation Recipients Prospective Observational Study
Completed NCT02714361 - A Study to Investigate the Effect of Vitamin D3 Supplementation on Iron Status in Iron Deficient Women N/A
Completed NCT02906319 - Vitamin D and HbA1c Levels in Diabetic Patients With CKD N/A
Completed NCT03203382 - Corneal Nerve Structure in Sjogren's
Completed NCT02118129 - Vitamin D Among Young Adults: an Intervention Study Using a Mobile 'App'. N/A
Not yet recruiting NCT01419821 - Vitamin D and Its Affect on Growth Rates and Bone Mineral Density Until Age 5 N/A
Completed NCT02187146 - The Effects of Serum Vitamin D and IVF Outcome N/A
Completed NCT02275650 - The Role of Narrowband Ultraviolet B Exposure in the Maintenance of Vitamin D Levels During Winter N/A
Completed NCT01688102 - The Effect of Oral Vitamin D Versus Narrow-Band UV-B Exposure on the Lipid Profile N/A
Completed NCT01651000 - Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D Insufficiency Phase 3